Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Autoimmune Diseases of the Nervous System
- A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease
- Universal Chimeric Antigen Receptor T-Cell UCAR T-cell Therapy Targeting CD19/B Cell Maturation Antigen CD19/BCMA in Patients With r/r Neurological Autoimmune Diseases
- Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
- JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
- Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants
- PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF
- IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis
- A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)
- Phase 1 Study of ART5803 in Healthy Participants
- A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
- Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis
- Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
- TPN-101 in Aicardi-Goutières Syndrome (AGS)
- Inhibition of Reverse Transcription in Aicardi-Goutières Syndrome
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Idiopathic Inflammatory Diseases of the Nervous System
- JAK Inhibitor Treatment in AGS
- Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis
- Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome
- Reverse Transcriptase Inhibitors in AGS
- IVIG Treatment for Refractory Immune-Related Adult Epilepsy
- Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
- Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
- A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)